Who is sponsoring NCT04232475?

NCT04232475 is sponsored by San Diego State University.

What drugs are being tested in NCT04232475?

Interventions in NCT04232475: 1 minute of stair climbing and descending, 3 minute of stair climbing and descending, 10 minute of stair climbing and descending.

What condition does NCT04232475 study?

NCT04232475 studies Postprandial Blood Glucose.

Is NCT04232475 still recruiting?

NCT04232475 is currently completed. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04232475

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Stair Climbing and Descending on Postprandial Blood Glucose

Completed NA Last updated 18 January 2020

What this trial tests

NA trial testing 1 minute of stair climbing and descending in Postprandial Blood Glucose in 30 participants. Completed in 1 January 2020.

Timeline

1 January 2018

Primary endpoint
1 January 2019

1 January 2020

Quick facts

Lead sponsor	San Diego State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	30
Start date	1 January 2018
Primary completion	1 January 2019
Estimated completion	1 January 2020
Sites	1 location across United States

Drugs / interventions tested

1 minute of stair climbing and descending
3 minute of stair climbing and descending
10 minute of stair climbing and descending

Conditions studied

Postprandial Blood Glucose — all drugs for Postprandial Blood Glucose →

Sponsor

San Diego State University

Who can join

Adults 18 to 45, any sex, with Postprandial Blood Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine effect of stair climbing and descending on postprandial blood glucose

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

One minute of stair climbing and descending reduces postprandial insulin and glucose with 3-min improving insulin resistance following a mixed meal in young adults: A Randomized Controlled Crossover Trial.
Moore JM, Salmons H, Vinoskey C, Hooshmand S, et al · · 2024 · cited 1× · PMID 38572086 · DOI 10.1016/j.jesf.2024.03.004

Verify or expand the search:

Other San Diego State University trials

Trials by the same sponsor.

NCT06900634 — Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partner · NA · not yet recruiting
NCT07271290 — Preventing Noise Exposure in Farmworkers · NA · not yet recruiting
NCT07010133 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3) · NA · not yet recruiting
NCT06753123 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2) · NA · not yet recruiting
NCT06635642 — Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04232475 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by San Diego State University
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04232475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing